×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [43]
上海药物研究所 [1]
内容类型
期刊论文 [36]
会议论文 [8]
发表日期
2019 [7]
2018 [5]
2017 [3]
2016 [4]
2015 [9]
2014 [12]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共44条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:
Li, Qiao
;
Guan, Xiuwen
;
Chen, Shanshan
;
Yi, Zongbi
;
Lan, Bo
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2020/07/01
Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis
期刊论文
2019, 卷号: 11, 页码: 4699-4706
作者:
Han, Yiqun
;
Wang, Jiayu
;
Liu, Weiming
;
Yuan, Peng
;
Li, Qing
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
trastuzumab
retreatment
HER2-positive cancer
metastatic cancer of the breast
progression therapy
Relationship between Ki67 and the efficacy of neoadjuvant chemotherapy: clinicopathological characteristics of luminal B breast cancer
期刊论文
2019, 卷号: 12, 期号: 5, 页码: 6044-6048
作者:
Wang, Jiayu
;
Sang, Die
;
Xu, Binghe
;
Yuan, Peng
;
Ma, Fei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Luminal B breast cancer
Ki-67
NCT
ROC curve
clinicopathological characteristics
prediction
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
期刊论文
2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:
Li Qiao
;
Guan Xiuwen
;
Chen Shanshan
;
Yi Zongbi
;
Lan Bo
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study
期刊论文
2019, 卷号: 17, 期号: 6, 页码: 4768-4778
作者:
Zhu, Anjie
;
Yuan, Peng
;
Wang, Jiayu
;
Fan, Ying
;
Luo, Yang
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
locally advanced or distantly metastatic breast cancer
pre-treatment
apatinib
chemotherapy
proteinuria
real-world clinical practice
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China
期刊论文
2019, 卷号: 19, 期号: 2, 页码: E370-E375
作者:
Lan, Bo
;
Ma, Fei
;
Han, Mei
;
Chen, Shanshan
;
Wang, Wenna
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/01/03
Chinese breast cancer patients
Disease free survival
Endocrine therapy
Single nucleotide polymorphism
UDP-glucuronosyltransferases 1A4
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 1
作者:
Guan, Xiuwen
;
Ma, Fei
;
Li, Chunxiao
;
Wu, Shiyang
;
Hu, Shangying
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Breast cancer
Circulating tumor cells
Epithelial-mesenchymal transition
Prognosis
Therapeutic implication
Phase I safety and pharmacokinetic study of cipatinib, an original dual tyrosine kinase inhibitor
期刊论文
2018, 卷号: 9, 期号: 8, 页码: 1041-1047
作者:
Wang, Jiayu
;
Han, Yiqun
;
Shi, Xiuqing
;
Li, Qing
;
Zhang, Pin
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Advanced breast cancer
cipatinib
HER2
phase I trial
RTKs
TNM stage at diagnosis is more predictive of prognosis than pathological complete response in young breast cancer treated with neoadjuvant chemotherapy
期刊论文
2018, 卷号: 29, 期号: 2, 页码: 176-183
作者:
Wang, Jingjing
;
Li, Qing
;
Zhang, Pin
;
Yuan, Peng
;
Ma, Fei
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
breast cancer
neoadjuvant chemotherapy
prognosis
young age
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China
期刊论文
2018, 卷号: 143, 期号: 10, 页码: 2499-2504
作者:
Lan, Bo
;
Ma, Fei
;
Chen, Shanshan
;
Wang, Wenna
;
Li, Qiao
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
breast cancer
TAM
TOR
CYP2D6
SNP
©版权所有 ©2017 CSpace - Powered by
CSpace